Biomarkers in motor neuron disease: a state of the art review

NS Verber, SR Shepheard, M Sassani… - Frontiers in …, 2019 - frontiersin.org
Motor neuron disease can be viewed as an umbrella term describing a heterogeneous
group of conditions, all of which are relentlessly progressive and ultimately fatal. The …

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis

JS Katzeff, F Bright, K Phan, JJ Kril, LM Ittner… - Brain, 2022 - academic.oup.com
Frontotemporal dementia refers to a group of neurodegenerative disorders characterized by
behaviour and language alterations and focal brain atrophy. Amyotrophic lateral sclerosis is …

The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder

S Dhasmana, A Dhasmana, AS Narula, M Jaggi… - Life Sciences, 2022 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurological disease affecting
both upper and lower motor neurons. In the United States alone, there are 16,000–20,000 …

Peripheral glycolysis in neurodegenerative diseases

SM Bell, T Burgess, J Lee, DJ Blackburn… - International journal of …, 2020 - mdpi.com
Neurodegenerative diseases are a group of nervous system conditions characterised
pathologically by the abnormal deposition of protein throughout the brain and spinal cord …

Extracellular RNAs as biomarkers of sporadic amyotrophic lateral sclerosis and other neurodegenerative diseases

T Hosaka, T Yamashita, A Tamaoka… - International Journal of …, 2019 - mdpi.com
Recent progress in the research for underlying mechanisms in neurodegenerative diseases,
including Alzheimer disease (AD), Parkinson disease (PD), and amyotrophic lateral …

[HTML][HTML] A review of biomarkers of amyotrophic lateral sclerosis: a pathophysiologic approach

RS Alshehri, AR Abuzinadah, MS Alrawaili… - International Journal of …, 2024 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive degeneration of upper and lower motor neurons. The heterogeneous nature of …

P75 neurotrophin receptor as a therapeutic target for drug development to treat neurological diseases

LL Xiong, L Chen, IB Deng, XF Zhou… - European Journal of …, 2022 - Wiley Online Library
The interaction of neurotrophins with their receptors is involved in the pathogenesis and
progression of various neurological diseases, including Alzheimer's disease, Parkinson's …

Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis

WM Stansberry, BA Pierchala - Frontiers in Molecular Neuroscience, 2023 - frontiersin.org
The discovery of the neurotrophins and their potent survival and trophic effects led to great
enthusiasm about their therapeutic potential to rescue dying neurons in neurodegenerative …

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study) …

S Vucic, J Ryder, L Mekhael, RD Henderson… - Medicine, 2020 - journals.lww.com
Background: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal
neurodegenerative disorder of the human motor system. Neuroinflammation appears to be …

Urinary p75ECD levels in patients with amyotrophic lateral sclerosis: a meta-analysis

G Shi, S Shao, J Zhou, K Huang… - … Lateral Sclerosis and …, 2022 - Taylor & Francis
Objective: p75 neurotrophin receptor (p75NTR) is associated with the pathogenesis of
amyotrophic lateral sclerosis (ALS). However, its role is not fully understood. The aim of this …